{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:36:39Z","timestamp":1759937799441},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:p>A small number of studies have investigated breast cancer (BC) risk among women with a history of false-positive recall (FPR) in BC screening, but none of them has used time-to-event analysis while at the same time quantifying the effect of false-negative diagnostic assessment (FNDA). FNDA occurs when screening detects BC, but this BC is missed on diagnostic assessment (DA). As a result of FNDA, screenings that detected cancer are incorrectly classified as FPR. Our study linked data recorded in the Flemish BC screening program (women aged 50\u201369 years) to data from the national cancer registry. We used Cox proportional hazards models on a retrospective cohort of 298\u2009738 women to assess the association between FPR and subsequent BC, while adjusting for potential confounders. The mean follow-up was 6.9 years. Compared with women without recall, women with a history of FPR were at an increased risk of developing BC [hazard ratio=2.10 (95% confidence interval: 1.92\u20132.31)]. However, 22% of BC after FPR was due to FNDA. The hazard ratio dropped to 1.69 (95% confidence interval: 1.52\u20131.87) when FNDA was excluded. Women with FPR have a subsequently increased BC risk compared with women without recall. The risk is higher for women who have a FPR BI-RADS 4 or 5 compared with FPR BI-RADS 3. There is room for improvement of diagnostic assessment: 41% of the excess risk is explained by FNDA after baseline screening.<\/jats:p>","DOI":"10.1097\/cej.0000000000000313","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T11:41:08Z","timestamp":1475667668000},"page":"396-403","source":"Crossref","is-referenced-by-count":7,"title":["Breast cancer risk is increased in the years following false-positive breast cancer screening"],"prefix":"10.1097","volume":"26","author":[{"given":"Mathijs C.","family":"Goossens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"De Brabander","sequence":"additional","affiliation":[{"name":"Belgian Cancer Registry"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"De Greve","sequence":"additional","affiliation":[{"name":"Vrije Universiteit Brussel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Vaes","sequence":"additional","affiliation":[{"name":"Belgian Cancer Registry"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Van Ongeval","sequence":"additional","affiliation":[{"name":"University Hospital Leuven"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Van Herck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliane","family":"Kellen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230901","first-page":"CD006776","article-title":"Using alternative statistical formats for presenting risks and risk reductions","volume":"3","author":"Akl","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/eurpub\/ckr057","article-title":"Effect of false-positive results on reattendance at breast cancer screening programmes in Spain","volume":"22","author":"Alamo-Junquera","year":"2011","journal-title":"Eur J Public Health"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/02841860801935483","article-title":"Participation behaviour following a false positive test in the Copenhagen mammography screening programme","volume":"47","author":"Bangsboll-Andersen","year":"2008","journal-title":"Acta Oncol"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/djj331","article-title":"Prospective BC risk prediction model for women undergoing screening mammography","volume":"98","author":"Barlow","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0110207","article-title":"Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme","volume":"9","author":"Blanch","year":"2014","journal-title":"Plos One"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/crad.2001.0662","article-title":"False-negative breast screening assessment: what lessons can we learn?","volume":"5","author":"Burrell","year":"2001","journal-title":"Clin Radiol"},{"key":"R7-20230901","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/jech.2005.042119","article-title":"Cumulative false positive recall rate and association with participant related factors in a population based BC screening programme","volume":"60","author":"Castells","year":"2006","journal-title":"J Epidemiol Community Health"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canep.2012.10.004","article-title":"Breast cancer detection risk in screening mammography after a false-positive result","volume":"37","author":"Castells","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/jnci\/92.20.1657","article-title":"Predicting the cumulative risk of false-positive mammograms","volume":"92","author":"Christiansen","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-006-9425-3","article-title":"Minority report \u2013 false-negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis","volume":"1","author":"Ciatto","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/sj.bjc.6602158","article-title":"Mammography screening in the Netherlands: delay in the diagnosis of breast cancer after breast cancer screening","volume":"91","author":"Duijm","year":"2004","journal-title":"Br J Cancer"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ypmed.2014.10.019","article-title":"Quantifying independent risk factors for failing to rescreen in a breast cancer screening program in Flanders, Belgium","volume":"69","author":"Goossens","year":"2014","journal-title":"Prev Med"},{"key":"R13-20230901","first-page":"559","article-title":"Cumulative incidence in competing risks data and competing risks regression analysis","volume":"38","author":"Haesook","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bjc.6601073","article-title":"Breast cancer teams: the impact of constitution, new cancer workload, and methods of operation on their effectiveness","volume":"89","author":"Haward","year":"2003","journal-title":"Br J Cancer"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1158\/1055-9965.EPI-15-0623","article-title":"Increased risk of developing breast cancer after a false-positive screening mammogram","volume":"24","author":"Henderson","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1258\/jms.2012.012083","article-title":"False-positive results in mammographic screening for BC in Europe: a literature review and survey of service screening programmes","volume":"19","author":"Hofvind","year":"2012","journal-title":"J Med Screen"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/bjc.2013.177","article-title":"The benefits and harms of BC screening: an independent review","volume":"108","author":"Marmot","year":"2013","journal-title":"Br J Cancer"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1001\/archinte.167.19.2039","article-title":"Informed choice in mammography screening: a randomised trial for a decision aid for 70-year-old women","volume":"167","author":"Mathieu","year":"2007","journal-title":"Arch Int Med"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/0969141313499147","article-title":"The effect of false positive breast screening examinations on subsequent attendance: retrospective cohort study","volume":"20","author":"Maxwell","year":"2013","journal-title":"J Med Screen"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/bjc.1988.195","article-title":"Breast cancer risk for women with a false positive screening test","volume":"58","author":"Peeters","year":"1988","journal-title":"Br J Cancer"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/annonc\/mdm481","article-title":"European guidelines for quality assurance in BC screening and diagnosis. Fourth edition","volume":"19","author":"Perry","year":"2008","journal-title":"Ann Oncol"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(01)00585-X","article-title":"Variations in treatment and survival in breast cancer","volume":"2","author":"Purushotham","year":"2001","journal-title":"Lancet Oncol"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models","volume":"26","author":"Putter","year":"2007","journal-title":"Statist Med"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ndt\/gfq661","article-title":"The analysis of competing events like cause-specific mortality \u2013 beware of the Kaplan\u2013Meier method","volume":"26","author":"Verduijn","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/jnci\/djs176","article-title":"Risk of breast cancer after false-positive test results in screening mammography","volume":"104","author":"von Euler-Chelpin","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.canep.2014.06.006","article-title":"Increased risk of BC in women with false-positive test: the role of misclassification","volume":"38","author":"von Euler-Chelpin","year":"2014","journal-title":"Cancer Epidemiol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201709000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:06:55Z","timestamp":1693613215000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201709000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000313","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}